150 related articles for article (PubMed ID: 1661643)
1. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins.
Saha N; Roy AC; Teo SH; Tay JS; Ratnam SS
Clin Genet; 1991 Oct; 40(4):277-82. PubMed ID: 1661643
[TBL] [Abstract][Full Text] [Related]
2. Interrelationships of serum paraoxonase, serum lipids and apolipoproteins in normal pregnancy. A longitudinal study.
Roy AC; Loke DF; Saha N; Viegas OA; Tay JS; Ratnam SS
Gynecol Obstet Invest; 1994; 38(1):10-3. PubMed ID: 7959317
[TBL] [Abstract][Full Text] [Related]
3. Relationship of paraoxonase and serum lipids in Taiwan.
Lin TJ; Yang DY; Jiang DD; Hung DZ; Hsu CL; Tsai MS
Kaohsiung J Med Sci; 2002 Mar; 18(3):127-33. PubMed ID: 12149827
[TBL] [Abstract][Full Text] [Related]
4. Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease.
Azizi F; Rahmani M; Raiszadeh F; Solati M; Navab M
Coron Artery Dis; 2002 Feb; 13(1):9-16. PubMed ID: 11917194
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins.
Gómez-Coronado D; Alvarez JJ; Entrala A; Olmos JM; Herrera E; Lasunción MA
Atherosclerosis; 1999 Nov; 147(1):167-76. PubMed ID: 10525138
[TBL] [Abstract][Full Text] [Related]
6. The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease.
Paragh G; Seres I; Harangi M; Balogh Z; Illyés L; Boda J; Szilvássy Z; Kovács P
Diabetes Metab; 2003 Dec; 29(6):613-8. PubMed ID: 14707891
[TBL] [Abstract][Full Text] [Related]
7. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
[TBL] [Abstract][Full Text] [Related]
8. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.
Hegele RA; Brunt JH; Connelly PW
Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):89-95. PubMed ID: 7749820
[TBL] [Abstract][Full Text] [Related]
9. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
Rahmani M; Raiszadeh F; Allahverdian S; Kiaii S; Navab M; Azizi F
Atherosclerosis; 2002 Jun; 162(2):381-9. PubMed ID: 11996958
[TBL] [Abstract][Full Text] [Related]
10. Serum paraoxonase level and paraoxonase polymorphism in patients with acromegaly.
Arpaci D; Karakas Celik S; Can M; Ermiş E; Kuzu F; Kokturk F; Hamamcioglu AC; Dursun A; Bayraktaroglu T
Redox Rep; 2016 Nov; 21(6):281-6. PubMed ID: 26863932
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase (PON1) polymorphism & its relation with lipids in north west Indian Punjabis.
Singh S; Verma M; Nain CK; Leelamma CO; Goel RC
Indian J Med Res; 1999 Oct; 110():133-7. PubMed ID: 10645101
[TBL] [Abstract][Full Text] [Related]
12. Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia.
Paragh G; Törocsik D; Seres I; Harangi M; Illyés L; Balogh Z; Kovács P
Curr Med Res Opin; 2004 Aug; 20(8):1321-7. PubMed ID: 15324535
[TBL] [Abstract][Full Text] [Related]
13. Serum paraoxonase polymorphism in three populations of southeast Asia.
Roy AC; Saha N; Tay JS; Ratnam SS
Hum Hered; 1991; 41(4):265-9. PubMed ID: 1664414
[TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.
Schulpis KH; Bartzeliotou A; Tsakiris S; Gounaris A; Papassotiriou I
Eur J Clin Nutr; 2007 Jun; 61(6):803-8. PubMed ID: 17203019
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients.
Rahimi-Ardabili B; Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Naghavi-Behzad M; Ghorashi S; Nezami N
Ren Fail; 2012; 34(9):1123-8. PubMed ID: 22950600
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
17. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
[TBL] [Abstract][Full Text] [Related]
18. The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase.
Kassai A; Illyés L; Mirdamadi HZ; Seres I; Kalmár T; Audikovszky M; Paragh G
Clin Biochem; 2007 Jan; 40(1-2):1-5. PubMed ID: 16999950
[TBL] [Abstract][Full Text] [Related]
19. Effect of walnut-enriched meat on the relationship between VCAM, ICAM, and LTB4 levels and PON-1 activity in ApoA4 360 and PON-1 allele carriers at increased cardiovascular risk.
Canales A; Sánchez-Muniz FJ; Bastida S; Librelotto J; Nus M; Corella D; Guillen M; Benedi J
Eur J Clin Nutr; 2011 Jun; 65(6):703-10. PubMed ID: 21407247
[TBL] [Abstract][Full Text] [Related]
20. Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study.
Srinivasan SR; Ehnholm C; Wattigney WA; Berenson GS
Atherosclerosis; 1996 Nov; 127(1):73-9. PubMed ID: 9006807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
